HEADER HYDROLASE 14-OCT-15 5E98 TITLE CRYSTAL STRUCTURE OF HUMAN HEPARANASE IN COMPLEX WITH HEPMER M04S02A COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPARANASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ENDO-GLUCORONIDASE,HEPARANASE-1,HPA1; COMPND 5 EC: 3.2.1.166; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: HEPARANASE; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: ENDO-GLUCORONIDASE,HEPARANASE-1,HPA1; COMPND 11 EC: 3.2.1.166; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 14 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 15 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS GLYCOSIDE HYDROLASE, HEPARAN, PROTEIN, SUGAR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR L.WU,G.J.DAVIES REVDAT 7 10-JAN-24 5E98 1 HETSYN REVDAT 6 29-JUL-20 5E98 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 15-JUL-20 5E98 1 COMPND KEYWDS REMARK HET REVDAT 5 2 1 HETNAM FORMUL HELIX SHEET REVDAT 5 3 1 SSBOND LINK SITE SCALE REVDAT 5 4 1 ATOM REVDAT 4 04-MAY-16 5E98 1 TITLE REVDAT 3 16-DEC-15 5E98 1 JRNL REVDAT 2 02-DEC-15 5E98 1 JRNL REVDAT 1 18-NOV-15 5E98 0 JRNL AUTH L.WU,C.M.VIOLA,A.M.BRZOZOWSKI,G.J.DAVIES JRNL TITL STRUCTURAL CHARACTERIZATION OF HUMAN HEPARANASE REVEALS JRNL TITL 2 INSIGHTS INTO SUBSTRATE RECOGNITION. JRNL REF NAT.STRUCT.MOL.BIOL. V. 22 1016 2015 JRNL REFN ESSN 1545-9985 JRNL PMID 26575439 JRNL DOI 10.1038/NSMB.3136 REMARK 2 REMARK 2 RESOLUTION. 1.63 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.63 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 61968 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : FROM APO STRUCTURE REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.975 REMARK 3 FREE R VALUE TEST SET COUNT : 3083 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.63 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4323 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.63 REMARK 3 BIN R VALUE (WORKING SET) : 0.3000 REMARK 3 BIN FREE R VALUE SET COUNT : 215 REMARK 3 BIN FREE R VALUE : 0.2830 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3643 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 97 REMARK 3 SOLVENT ATOMS : 243 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.14000 REMARK 3 B22 (A**2) : -1.09600 REMARK 3 B33 (A**2) : -0.10500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.35100 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.086 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.089 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.070 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.135 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.975 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.963 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3838 ; 0.012 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 3604 ; 0.002 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5206 ; 1.748 ; 1.677 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8370 ; 1.412 ; 1.604 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 459 ; 6.696 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 181 ;34.901 ;21.823 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 648 ;13.778 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;14.509 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 494 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4182 ; 0.010 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 819 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 722 ; 0.235 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 31 ; 0.302 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1861 ; 0.174 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 209 ; 0.165 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1839 ; 3.203 ; 3.366 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1838 ; 3.194 ; 3.364 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2297 ; 4.435 ; 5.036 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2298 ; 4.435 ; 5.038 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1999 ; 4.349 ; 3.987 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1996 ; 4.352 ; 3.984 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2909 ; 6.442 ; 5.756 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2908 ; 6.439 ; 5.755 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 5E98 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-OCT-15. REMARK 100 THE DEPOSITION ID IS D_1000214563. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61989 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.630 REMARK 200 RESOLUTION RANGE LOW (A) : 38.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.63 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.67 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 1.07700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 5E8M REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES [5.5] 0.1 M MGCL2 17% REMARK 280 PEG3350, PH 5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.64500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 155 REMARK 465 PRO A 156 REMARK 465 GLY A 157 REMARK 465 LYS A 158 REMARK 465 ASP B 33 REMARK 465 PRO B 34 REMARK 465 GLY B 35 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H GLY A 350 HO6B BDP C 1 1.13 REMARK 500 HH11 ARG A 303 HO3 BDP C 3 1.24 REMARK 500 HE21 GLN A 270 H TYR A 298 1.33 REMARK 500 HG3 ARG A 428 O HOH A 1289 1.50 REMARK 500 HD21 ASN A 217 O HOH A 1104 1.52 REMARK 500 ND2 ASN A 459 C1 NAG A 1004 1.77 REMARK 500 ND2 ASN A 238 C1 NAG A 1003 2.08 REMARK 500 ND2 ASN A 200 C1 NAG A 1002 2.09 REMARK 500 O HOH A 1246 O HOH A 1282 2.19 REMARK 500 O5 BDP C 1 OH NPO A 1009 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 225 CD GLU A 225 OE2 0.085 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 333 -49.06 -135.49 REMARK 500 LEU A 355 -51.80 -124.33 REMARK 500 LEU A 419 -161.17 -119.02 REMARK 500 SER A 426 -119.24 38.21 REMARK 500 ARG A 429 -72.86 -123.52 REMARK 500 PRO A 469 32.57 -94.44 REMARK 500 ALA B 63 -38.83 -39.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG A 1002 REMARK 610 NAG A 1003 REMARK 610 NAG A 1004 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5E8M RELATED DB: PDB REMARK 900 SAME PROTEIN APO REMARK 900 RELATED ID: 5E97 RELATED DB: PDB REMARK 900 SAME PROTEIN DIFFERENT LIGAND REMARK 900 RELATED ID: 5E9B RELATED DB: PDB REMARK 900 SAME PROTEIN DIFFERENT LIGAND REMARK 900 RELATED ID: 5E9C RELATED DB: PDB REMARK 900 SAME PROTEIN DIFFERENT LIGAND DBREF 5E98 A 158 543 UNP Q9Y251 HPSE_HUMAN 158 543 DBREF 5E98 B 36 109 UNP Q9Y251 HPSE_HUMAN 36 109 SEQADV 5E98 ASP A 155 UNP Q9Y251 EXPRESSION TAG SEQADV 5E98 PRO A 156 UNP Q9Y251 EXPRESSION TAG SEQADV 5E98 GLY A 157 UNP Q9Y251 EXPRESSION TAG SEQADV 5E98 ARG A 307 UNP Q9Y251 LYS 307 CONFLICT SEQADV 5E98 ASP B 33 UNP Q9Y251 EXPRESSION TAG SEQADV 5E98 PRO B 34 UNP Q9Y251 EXPRESSION TAG SEQADV 5E98 GLY B 35 UNP Q9Y251 EXPRESSION TAG SEQRES 1 A 389 ASP PRO GLY LYS LYS PHE LYS ASN SER THR TYR SER ARG SEQRES 2 A 389 SER SER VAL ASP VAL LEU TYR THR PHE ALA ASN CYS SER SEQRES 3 A 389 GLY LEU ASP LEU ILE PHE GLY LEU ASN ALA LEU LEU ARG SEQRES 4 A 389 THR ALA ASP LEU GLN TRP ASN SER SER ASN ALA GLN LEU SEQRES 5 A 389 LEU LEU ASP TYR CYS SER SER LYS GLY TYR ASN ILE SER SEQRES 6 A 389 TRP GLU LEU GLY ASN GLU PRO ASN SER PHE LEU LYS LYS SEQRES 7 A 389 ALA ASP ILE PHE ILE ASN GLY SER GLN LEU GLY GLU ASP SEQRES 8 A 389 PHE ILE GLN LEU HIS LYS LEU LEU ARG LYS SER THR PHE SEQRES 9 A 389 LYS ASN ALA LYS LEU TYR GLY PRO ASP VAL GLY GLN PRO SEQRES 10 A 389 ARG ARG LYS THR ALA LYS MET LEU LYS SER PHE LEU LYS SEQRES 11 A 389 ALA GLY GLY GLU VAL ILE ASP SER VAL THR TRP HIS HIS SEQRES 12 A 389 TYR TYR LEU ASN GLY ARG THR ALA THR ARG GLU ASP PHE SEQRES 13 A 389 LEU ASN PRO ASP VAL LEU ASP ILE PHE ILE SER SER VAL SEQRES 14 A 389 GLN LYS VAL PHE GLN VAL VAL GLU SER THR ARG PRO GLY SEQRES 15 A 389 LYS LYS VAL TRP LEU GLY GLU THR SER SER ALA TYR GLY SEQRES 16 A 389 GLY GLY ALA PRO LEU LEU SER ASP THR PHE ALA ALA GLY SEQRES 17 A 389 PHE MET TRP LEU ASP LYS LEU GLY LEU SER ALA ARG MET SEQRES 18 A 389 GLY ILE GLU VAL VAL MET ARG GLN VAL PHE PHE GLY ALA SEQRES 19 A 389 GLY ASN TYR HIS LEU VAL ASP GLU ASN PHE ASP PRO LEU SEQRES 20 A 389 PRO ASP TYR TRP LEU SER LEU LEU PHE LYS LYS LEU VAL SEQRES 21 A 389 GLY THR LYS VAL LEU MET ALA SER VAL GLN GLY SER LYS SEQRES 22 A 389 ARG ARG LYS LEU ARG VAL TYR LEU HIS CYS THR ASN THR SEQRES 23 A 389 ASP ASN PRO ARG TYR LYS GLU GLY ASP LEU THR LEU TYR SEQRES 24 A 389 ALA ILE ASN LEU HIS ASN VAL THR LYS TYR LEU ARG LEU SEQRES 25 A 389 PRO TYR PRO PHE SER ASN LYS GLN VAL ASP LYS TYR LEU SEQRES 26 A 389 LEU ARG PRO LEU GLY PRO HIS GLY LEU LEU SER LYS SER SEQRES 27 A 389 VAL GLN LEU ASN GLY LEU THR LEU LYS MET VAL ASP ASP SEQRES 28 A 389 GLN THR LEU PRO PRO LEU MET GLU LYS PRO LEU ARG PRO SEQRES 29 A 389 GLY SER SER LEU GLY LEU PRO ALA PHE SER TYR SER PHE SEQRES 30 A 389 PHE VAL ILE ARG ASN ALA LYS VAL ALA ALA CYS ILE SEQRES 1 B 77 ASP PRO GLY GLN ASP VAL VAL ASP LEU ASP PHE PHE THR SEQRES 2 B 77 GLN GLU PRO LEU HIS LEU VAL SER PRO SER PHE LEU SER SEQRES 3 B 77 VAL THR ILE ASP ALA ASN LEU ALA THR ASP PRO ARG PHE SEQRES 4 B 77 LEU ILE LEU LEU GLY SER PRO LYS LEU ARG THR LEU ALA SEQRES 5 B 77 ARG GLY LEU SER PRO ALA TYR LEU ARG PHE GLY GLY THR SEQRES 6 B 77 LYS THR ASP PHE LEU ILE PHE ASP PRO LYS LYS GLU HET BDP C 1 20 HET GNS C 2 25 HET BDP C 3 20 HET IMD A1001 13 HET NAG A1002 28 HET NAG A1003 28 HET NAG A1004 28 HET CL A1005 1 HET NPO A1009 16 HETNAM BDP BETA-D-GLUCOPYRANURONIC ACID HETNAM GNS 2-DEOXY-2-(SULFOAMINO)-ALPHA-D-GLUCOPYRANOSE HETNAM IMD IMIDAZOLE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CL CHLORIDE ION HETNAM NPO P-NITROPHENOL HETSYN BDP BETA-D-GLUCURONIC ACID; D-GLUCURONIC ACID; GLUCURONIC HETSYN 2 BDP ACID HETSYN GNS N-SULFO-ALPHA-D-GLUCOSAMINE; 2-DEOXY-2-(SULFOAMINO)- HETSYN 2 GNS ALPHA-D-GLUCOSE; 2-DEOXY-2-(SULFOAMINO)-D-GLUCOSE; 2- HETSYN 3 GNS DEOXY-2-(SULFOAMINO)-GLUCOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 BDP 2(C6 H10 O7) FORMUL 3 GNS C6 H13 N O8 S FORMUL 4 IMD C3 H5 N2 1+ FORMUL 5 NAG 3(C8 H15 N O6) FORMUL 8 CL CL 1- FORMUL 9 NPO C6 H5 N O3 FORMUL 10 HOH *243(H2 O) HELIX 1 AA1 SER A 166 GLY A 181 1 16 HELIX 2 AA2 SER A 201 LYS A 214 1 14 HELIX 3 AA3 GLU A 225 ASN A 227 5 3 HELIX 4 AA4 SER A 228 ASP A 234 1 7 HELIX 5 AA5 ASN A 238 LYS A 255 1 18 HELIX 6 AA6 ARG A 272 GLY A 287 1 16 HELIX 7 AA7 THR A 306 LEU A 311 1 6 HELIX 8 AA8 ASN A 312 ASP A 317 1 6 HELIX 9 AA9 ASP A 317 SER A 332 1 16 HELIX 10 AB1 THR A 358 ALA A 360 5 3 HELIX 11 AB2 ALA A 361 GLY A 376 1 16 HELIX 12 AB3 LEU A 401 LEU A 413 1 13 HELIX 13 AB4 HIS A 486 SER A 490 5 5 HELIX 14 AB5 VAL A 539 ILE A 543 5 5 HELIX 15 AB6 ASN B 64 ASP B 68 5 5 HELIX 16 AB7 ARG B 70 SER B 77 1 8 HELIX 17 AB8 SER B 77 LEU B 87 1 11 HELIX 18 AB9 GLY B 96 ASP B 100 5 5 SHEET 1 AA1 2 SER A 163 TYR A 165 0 SHEET 2 AA1 2 LEU B 102 PHE B 104 1 O ILE B 103 N SER A 163 SHEET 1 AA2 9 LEU A 182 LEU A 188 0 SHEET 2 AA2 9 SER A 219 LEU A 222 1 O SER A 219 N PHE A 186 SHEET 3 AA2 9 LEU A 263 VAL A 268 1 O TYR A 264 N TRP A 220 SHEET 4 AA2 9 SER A 292 ASN A 301 1 O HIS A 296 N VAL A 268 SHEET 5 AA2 9 LYS A 338 TYR A 348 1 O TRP A 340 N VAL A 293 SHEET 6 AA2 9 VAL A 380 ARG A 382 1 O MET A 381 N LEU A 341 SHEET 7 AA2 9 LEU B 57 ASP B 62 1 O SER B 58 N VAL A 380 SHEET 8 AA2 9 ALA B 90 GLY B 95 1 O ARG B 93 N ILE B 61 SHEET 9 AA2 9 LEU A 182 LEU A 188 1 N ILE A 185 O PHE B 94 SHEET 1 AA3 4 LEU A 498 THR A 499 0 SHEET 2 AA3 4 VAL A 493 LEU A 495 -1 N LEU A 495 O LEU A 498 SHEET 3 AA3 4 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA3 4 LYS A 514 PRO A 515 -1 O LYS A 514 N LYS A 477 SHEET 1 AA4 8 LEU A 498 THR A 499 0 SHEET 2 AA4 8 VAL A 493 LEU A 495 -1 N LEU A 495 O LEU A 498 SHEET 3 AA4 8 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA4 8 SER A 528 ILE A 534 -1 O PHE A 531 N TYR A 478 SHEET 5 AA4 8 LEU A 450 ASN A 456 -1 N ASN A 456 O SER A 528 SHEET 6 AA4 8 LEU A 431 THR A 438 -1 N HIS A 436 O THR A 451 SHEET 7 AA4 8 VAL A 414 VAL A 418 -1 N GLY A 415 O CYS A 437 SHEET 8 AA4 8 HIS B 50 LEU B 51 -1 O HIS B 50 N VAL A 418 SHEET 1 AA5 4 MET A 420 VAL A 423 0 SHEET 2 AA5 4 VAL B 38 PHE B 44 -1 O PHE B 44 N MET A 420 SHEET 3 AA5 4 LYS A 462 ARG A 465 1 N ARG A 465 O VAL B 39 SHEET 4 AA5 4 LEU A 522 LEU A 524 -1 O LEU A 522 N LEU A 464 SSBOND 1 CYS A 437 CYS A 542 1555 1555 1.99 LINK OH NPO A1009 C1 BDP C 1 1555 1555 1.42 LINK O4 BDP C 1 C1 GNS C 2 1555 1555 1.44 LINK O4 GNS C 2 C1 BDP C 3 1555 1555 1.44 CISPEP 1 GLY A 265 PRO A 266 0 0.44 CISPEP 2 GLN A 383 VAL A 384 0 -7.21 CISPEP 3 TYR A 468 PRO A 469 0 1.84 CISPEP 4 GLY A 484 PRO A 485 0 4.51 CISPEP 5 SER B 88 PRO B 89 0 -0.25 CRYST1 45.790 71.290 77.920 90.00 95.06 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021839 0.000000 0.001934 0.00000 SCALE2 0.000000 0.014027 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012884 0.00000